Four weeks from today, many of us will be dallying at the JP Morgan Healthcare Conference that’s held Jan. 12-15 in San Francisco. Now’s the time to start planning – what to say to that private equity partner waiting for coffee next to you; how to separate the startup wheat from chaff; which grey suit’s the best grey suit for that investor presentation.
For the fellow JP Morgan neophyte, here’s a compilation of some sagely advice:
Top 10 Little White Lies told at the JP Morgan Healthcare Conference
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This listicle from Life Sci VC Bruce Booth is damned hilarious, with said lies including:
“We add more than just capital.” Translation: We are thinking of “rolling our sleeves up” and replacing you. Translation #2: We definitely will add more chaos to Board meetings.
“That was a great discussion of your portfolio/company; thanks – we’ll be in touch.” Translation: We won’t likely be in touch, at least until scheduling the [next] JPM meeting. But thanks for chatting with us.
“You guys don’t seem like other VCs.” Translation: You just might be an even bigger #@!$ than the other VCs we’ve met.
10 Tips for Maximizing the JP Morgan Healthcare Experience
When Luke Timmerman was still at Xconomy, he jotted down a few pro tips for the biotech bender:
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Don’t get overscheduled. It’s normal to be such an eager beaver that you pack your entire calendar with 1-on-1 meetings, in 30-minute blocks, from 7 am to 6 pm every day. And that’s all before the evening receptions… But be warned. If you get overscheduled, you run the risk of having high quantity/low quality interactions. Even worse, you risk missing out on serendipitous encounters on the sidewalks, in the hallways, in the line at Starbucks.
Meet some new people, some old people, some random people doing cool stuff you know little about. This is about strategic networking. Part of the magic of JP Morgan is the sheer density, and diversity, of people in one place doing so many interesting things. It’s a great opportunity to strengthen your network by seeking out new people you want to know, and staying in touch with people who live far away.
Don’t get so focused on one thing you lose sight of the big picture. Everybody needs goals, and biotech requires an ability to intensely focus on that single goal for a long time. Maybe instead of spending 100 percent of the time trying to close that deal or woo the investors to support your IPO, it would be wise to take the blinders off occasionally. Maybe that perfect VP of R&D candidate just shook your hand at a party, and you didn’t even know it because you were so distracted by thoughts of buttonholing the guy from OrbiMed in the corner.
JP Morgan: Where the Boys are… And not the Girls
Penned by Lisa Suennen, a managing partner at Venture Valkyrie Consulting, this is an astute take on the gender imbalance that continues to haunt JP Morgan. She writes:
In a field where women hold many senior positions in actual US healthcare corporations, they are drowned out at this conference by the advancing horde of finance guys in red ties and the CEOs that love them.
